Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals
09:59am, Monday, 01'st Dec 2025
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Moderna stock slides as FDA moves to tighten vaccine guidelines
07:44am, Monday, 01'st Dec 2025
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock fell sharply on the news that the Food and Drug Administration (FDA) plans to implement stricter approval...
First Look: Airbus drops, Crypto slides, Cyber Monday
07:37am, Monday, 01'st Dec 2025
Stock News Airbus shares sink on fresh A320 quality snag: Airbus (EADSY) fell after reports of an industrial quality issue affecting fuselage panels on dozens o
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
02:52pm, Saturday, 29'th Nov 2025
FDA's new vaccine strategy tightens approval rules after internal findings linked COVID-19 shots to several child deaths.
AI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?
03:14pm, Tuesday, 25'th Nov 2025
While most eyes are on tech and chipmakers, biotech is quietly staging its biggest rally in over two decades.
10,099 Shares in Moderna, Inc. $MRNA Acquired by AXQ Capital LP
03:34am, Tuesday, 25'th Nov 2025
AXQ Capital LP purchased a new stake in shares of Moderna, Inc. (NASDAQ: MRNA) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 10,099 shares of the comp
Moderna, Inc. (MRNA) Analyst/Investor Day Transcript
08:03pm, Monday, 24'th Nov 2025
Moderna, Inc. ( MRNA ) Analyst/Investor Day November 20, 2025 9:00 AM EST Company Participants Stéphane Bancel - CEO & Director Stephen Hoge - President Jerh Collins - Chief Technical Operations & Qu
Creative Planning Increases Stock Holdings in Moderna, Inc. $MRNA
04:10am, Monday, 24'th Nov 2025
Creative Planning boosted its stake in Moderna, Inc. (NASDAQ: MRNA) by 19.4% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 107,593 shares of the compa
First-Ever Human H5N5 Case Turns Fatal In Washington State
01:07pm, Saturday, 22'nd Nov 2025
Washington reports world's first fatal human H5N5 bird flu case; officials say risk to public remains low, monitoring continues closely.
Moderna takes $1.5 billion loan, expects 10% revenue growth next year
07:03am, Thursday, 20'th Nov 2025
Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue growth next year.
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
07:00am, Thursday, 20'th Nov 2025
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
07:00am, Thursday, 20'th Nov 2025
Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash b
Moderna to complete US mRNA manufacturing network with $140 million investment
08:44am, Wednesday, 19'th Nov 2025
Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities
07:00am, Wednesday, 19'th Nov 2025
New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled biomanufacturi
Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
07:00am, Tuesday, 18'th Nov 2025
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference: Piper Sandler's 37th Annu
